POLYETHYLENE GLYCOL 3350- polyethylene glycol 3350 powder, for solution 
ATLANTIC BIOLOGICALS CORP.

----------

Polyethylene Glycol 3350, NF Powder for Oral Solution

Drug Facts

Active ingredient (in each dose)

Polyethylene Glycol 3350, 17 grams (cup filled to the indicated "17 GRAMS" line)

Purpose

Osmotic Laxative

Use

Warnings

Allergy alert

Do not use if you are allergic to polyethylene glycol

Do not use if you have kidney disease, except under the advice and supervision of a doctor.

Ask a doctor before use if you have

  • nausea, vomiting, or abdominal pain
  • a sudden change in bowel habits that lasts over 2 weeks
  • irritable bowel syndrome

Ask a doctor or pharmacist before use if you are taking a prescription drug.

When using this product you may have loose, watery, more frequent stools.

Stop use and ask a doctor if

  • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
  • you get diarrhea
  • you need to use a laxative for longer than 1 week

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

none

Questions or Comments?

call: 1-800-367-3395

Manufactured by:
LGM Pharma Solutions, LLC
Irvine, CA 92614

DISTRIBUTED BY: 

ATLANTIC BIOLOGICALS CORP.

MIAMI, FL 33179

PRINCIPAL DISPLAY PANEL - 510 g Bottle Label

Polyethylene Glycol

3350 NF

Powder For Solution,
Osmotic Laxative

image 1

image 2

image 3

image 4

POLYETHYLENE GLYCOL 3350 
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:17856-0962(NDC:51991-962)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (polyethylene glycol 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g  in 17 g
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:17856-0962-172 in 1 BOX, UNIT-DOSE02/17/2021
14 g in 1 POUCH; Type 0: Not a Combination Product
2NDC:17856-0962-272 in 1 BOX, UNIT-DOSE02/17/2021
24.25 g in 1 POUCH; Type 0: Not a Combination Product
3NDC:17856-0962-350 in 1 BOX, UNIT-DOSE02/17/2021
38.50 g in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
4NDC:17856-0962-472 in 1 BOX, UNIT-DOSE02/17/2021
48.50 g in 1 POUCH; Type 0: Not a Combination Product
5NDC:17856-0962-550 in 1 BOX, UNIT-DOSE06/08/2021
54.25 g in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09081203/27/2019
Labeler - ATLANTIC BIOLOGICALS CORP. (047437707)
Establishment
NameAddressID/FEIBusiness Operations
ATLANTIC BIOLOGICALS CORP.047437707relabel(17856-0962) , repack(17856-0962)

Revised: 6/2021
Document Id: 47096646-6119-4f5d-8b50-d58c4401a4fd
Set id: 4ef870f7-2f9f-4170-bc8d-6e9c52884c20
Version: 2
Effective Time: 20210608
 
ATLANTIC BIOLOGICALS CORP.